Primary |
Product Used For Unknown Indication |
66.7% |
Attention Deficit/hyperactivity Disorder |
16.7% |
Anxiety |
8.3% |
Huntington's Disease |
8.3% |
|
Chest Pain |
18.2% |
Medication Error |
18.2% |
Dyspnoea |
9.1% |
Pharmaceutical Product Complaint |
9.1% |
Product Quality Issue |
9.1% |
Rash |
9.1% |
Suicidal Ideation |
9.1% |
Tic |
9.1% |
Weight Increased |
9.1% |
|
Secondary |
Anxiety |
21.1% |
Attention Deficit/hyperactivity Disorder |
13.2% |
Ill-defined Disorder |
13.2% |
Bipolar Disorder |
10.5% |
Hypertension |
10.5% |
Autism |
5.3% |
Mood Swings |
5.3% |
Panic Attack |
5.3% |
Abnormal Behaviour |
2.6% |
Aggression |
2.6% |
Blood Cholesterol Increased |
2.6% |
Depression |
2.6% |
Schizophrenia |
2.6% |
Smoking Cessation Therapy |
2.6% |
|
Vomiting |
21.4% |
Accidental Exposure |
10.7% |
Renal Impairment |
7.1% |
Bipolar Disorder |
3.6% |
Blood Triglycerides Increased |
3.6% |
Drug Hypersensitivity |
3.6% |
Dyspnoea |
3.6% |
Electrocardiogram Qt Prolonged |
3.6% |
Hallucination |
3.6% |
Lipids Increased |
3.6% |
Medication Error |
3.6% |
Pain In Extremity |
3.6% |
Rash |
3.6% |
Restless Legs Syndrome |
3.6% |
Scotoma |
3.6% |
Skin Hyperpigmentation |
3.6% |
Skin Papilloma |
3.6% |
Suicide Attempt |
3.6% |
Tachycardia |
3.6% |
Tic |
3.6% |
|
Concomitant |
Attention Deficit/hyperactivity Disorder |
16.9% |
Hypertension |
15.0% |
Product Used For Unknown Indication |
10.1% |
Bipolar Disorder |
6.3% |
Hormone Replacement Therapy |
5.6% |
Depression |
5.5% |
Drug Use For Unknown Indication |
5.1% |
Diabetes Mellitus |
4.1% |
Asthma |
3.6% |
Osteoporosis |
3.2% |
Anxiety |
3.1% |
Menopause |
3.1% |
Affective Disorder |
2.7% |
Prophylaxis |
2.6% |
Gastrooesophageal Reflux Disease |
2.4% |
Lennox-gastaut Syndrome |
2.4% |
Autism |
2.2% |
Pain |
2.2% |
Acute Lymphocytic Leukaemia |
2.0% |
Sleep Disorder |
2.0% |
|
Weight Increased |
17.2% |
Suicidal Ideation |
8.2% |
Vomiting |
8.2% |
Spinal Osteoarthritis |
6.6% |
Weight Decreased |
5.7% |
Tic |
4.9% |
Tricuspid Valve Incompetence |
4.9% |
Weight Fluctuation |
4.9% |
Insomnia |
4.1% |
Off Label Use |
4.1% |
Sinusitis |
4.1% |
White Blood Cell Count Decreased |
4.1% |
Drug Dose Omission |
3.3% |
Product Quality Issue |
3.3% |
Renal Failure |
3.3% |
Somnolence |
3.3% |
Ageusia |
2.5% |
Application Site Irritation |
2.5% |
Arthritis Bacterial |
2.5% |
Blood Glucose Increased |
2.5% |
|
Interacting |
Drug Use For Unknown Indication |
100.0% |
|
|